Yu Yao

机构：Central South University, Tianjin University, ShanghaiTech University, Ningbo No. 2 Hospital, First Affiliated Hospital of Xi'an Jiaotong University, The Affiliated Yongchuan Hospital of Chongqing Medical University, Huashan Hospital, Xiangya Hospital Central South University, Ningbo No.6 Hospital, Ningbo First Hospital, Chongqing Medical University · ORCID：0000-0003-3618-2363

发表论文 190 篇 · 总被引 4856 次 · h-index 30

代表论文

• Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials (2025 · 癌症：英文版 · 被引 12)
• Wave energy converters: a comprehensive review of research progress, key challenges, and future trends (2026 · Applied Energy · 被引 7)
• Phase 3 study of benmelstobart in combination with chemotherapy followed by sequential combination with anlotinib for the first-line treatment of locally advanced or metastatic squamous non-small cell lung cancer (sq-NSCLC). (2025 · Journal of Clinical Oncology · 被引 5)
• Abstract CT008: First-in-human study of SYS6010, a novel EGFR targeting antibody drug conjugate (ADC) for patients with advanced solid tumors (2025 · Cancer Research · 被引 5)
• Splint RNA-mediated single-stranded DNA-encoded library construction and label-free live-cell selection (2026 · Chem · 被引 4)
• Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation (2025 · Cell Reports Medicine · 被引 4)